Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20552 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Deema I Fallatah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Immunoglobulin M, Cytomegalovirus Infections, Antibodies, Viral, Cytomegalovirus. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
Introduction
The presence of cytomegalovirus (CMV) immunoglobulin M (IgM) in human immunodeficiency virus (HIV)-positive individuals indicates an active infection or reactivation of the virus. Methodology: This study investigated the seroprevalence of CMV IgM antibodies among HIV-positive individuals attending the Ahmadu Bello University Teaching Hospital in Nigeria.
Results
Fifty nine out of 92 participants who were tested with an enzyme-linked immunosorbent assay (ELISA) were positive for CMV IgM, resulting in a prevalence rate of 64.1%. Analysis of sociodemographic variables revealed a statistically significant association between CMV IgM seropositivity, and both gender and residence of the participants. Clinical variables also indicated a significant association between CMV IgM seropositivity and the duration of HIV infection. Multivariate analysis showed that participants in the 18–29 years age group, those with a secondary education level, the unemployed, and those who had been infected with HIV for 1–3 years were most likely to test positive for CMV infection. Joint and muscle pain were the most commonly reported symptoms among participants.
Conclusions
The high seroprevalence of CMV IgM antibodies found in this study suggests that CMV infection is widespread in the study area. Therefore, it is essential to regularly screen HIV-positive individuals for CMV during routine antiretroviral therapy visits to enable early detection and improve treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Nigeria.
- Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Fallatah, D. I., Adekola, H. A., Mohammed, M., & AlQadeeb, H. (2025). Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20552
Vancouver
Fallatah DI, Adekola HA, Mohammed M, AlQadeeb H. Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20552
BibTeX
@article{Fallatah2025,
author = {Fallatah, Deema I and Adekola, Hafeez A and Mohammed, Musa and AlQadeeb, Hajar},
title = {Seroprevalence of IgM antibodies against cytomegalovirus (CMV) in HIV patients: single center study},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20552}
}
EUVIMED